Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers

(2019) Ruth Nussinov et al.   PLoS Computational Biology

Hepatocellular Carcinoma

(2019) Augusto Villanueva   NEW ENGLAND JOURNAL OF MEDICINE

NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein

(2019) Wan-Yu Li et al.   CANCER LETTERS

Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma

(2019) Manali Dimri et al.   HEPATOLOGY

Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma

(2019) Haoyu Sun et al.   Cancer Immunology Research

Role of the complement system in the tumor microenvironment

(2019) Ronghua Zhang et al.   Cancer Cell International

Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

(2018) Naoto Fujiwara et al.   JOURNAL OF HEPATOLOGY

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

(2018) Fabio Conforti et al.   LANCET ONCOLOGY

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

(2018) Xiangkun Wang et al.   Cancer Medicine

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy

(2018) Terry R. Medler et al.   CANCER CELL

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy

(2018) Renumathy Dhanasekaran et al.   GASTROENTEROLOGY

Comprehensive molecular and immunological characterization of hepatocellular carcinoma

(2018) Shu Shimada et al.   EBioMedicine

Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer

(2017) Hyun Goo Woo et al.   Nature Communications

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

(2016) Roberta Bulla et al.   Nature Communications

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

(2015) Marta Garnelo et al.   GUT

Advances in targeted therapies for hepatocellular carcinoma in the genomic era

(2015) Josep M. Llovet et al.   Nature Reviews Clinical Oncology

Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in Human Liver Cells and Association with Hepatocellular Carcinoma

(2015) Dianke Yu et al.   Scientific Reports

Hepatocellular carcinoma: clinical frontiers and perspectives

(2014) Jordi Bruix et al.   GUT

Complement genetics, deficiencies, and disease associations

(2012) Karine R. Mayilyan   Protein & Cell

Sex Disparities in Cancer Mortality and Survival

(2011) M. B. Cook et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma

(2011) Augusto Villanueva et al.   GASTROENTEROLOGY

Sex Disparities in Cancer Incidence by Period and Age

(2009) M. B. Cook et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION